G. Riely
Memorial Sloan Kettering Cancer Center(US)Kettering University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Prostate Cancer Diagnosis and Treatment
Most-Cited Works
- → International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary(2011)594 cited
- → MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB(2018)30 cited
- → What, When, and How of Biomarker Testing in Non–Small Cell Lung Cancer(2017)24 cited
- → OA02.03 Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6(2018)18 cited
- Updated Antitumor Activity of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer(2018)
- → MA06.13 Updated Safety Analysis of Encorafenib Plus Binimetinib in Patients with BRAF V600e-Mutant Metastatic NSCLC from PHAROS Study(2024)
- → P2.06.12 TP53/RB1-Mutant Squamous Cell Lung Cancers: Clinicopathologic Features and Outcomes(2025)
- → Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung(2005)
- → P3.12.13 Long-Term Real-World Outcomes of Sotorasib in Second-Line and Beyond Treatment of KRAS G12C-Mutated Advanced NSCLC(2025)
- → Abstract A013: Genomic prognostic biomarkers in prostate cancer from the AACR GENIE cohort(2026)